James R. Berenson
Researcher from Institute for Myeloma and Bone Cancer Research
Best podcasts with James R. Berenson
Ranked by the Snipd community
Feb 7, 2024 • 3min
Evaluation of Ruxolitinib, a Janus Kinase Inhibitor, in Multiple Myeloma
Researchers Ashley Del Dosso, Elizabeth Tadevosyan, and James R. Berenson discuss the role of Janus Kinase inhibitors in treating multiple myeloma, exploring their effectiveness in overcoming treatment resistance. They also delve into the studies on Ruxolitinib in preclinical and clinical settings for the treatment of relapsed refractory multiple myeloma.
